Back
EyePoint Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
EYPT
EyePoint Pharmaceuticals
Last Price:
9.13
Seasonality Move:
28.93%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.EyePoint Pharmaceuticals Price Quote
$9.13
+0.78 (+9.34%)
(Updated: November 22, 2024 at 11:45 AM ET)
EyePoint Pharmaceuticals Key Stats
Buy
55
EyePoint Pharmaceuticals (EYPT)
is a Buy
Day range:
$8.25 - $9.07
52-week range:
$5.86 - $30.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.26
P/B ratio:
2.61%
Volume:
2.5M
Avg. volume:
1.1M
1-year change:
36.44%
Market cap:
$569.9M
Revenue:
$46M
EPS:
$-1.99
How Much Does EyePoint Pharmaceuticals Make?
-
How Much Are EyePoint Pharmaceuticals's Sales Annually?
EYPT Revenues are $46M -
How Much Profit Does EyePoint Pharmaceuticals's Make A Year?
EYPT net income is -$70.8M
Is EyePoint Pharmaceuticals Growing As A Company?
-
What Is EyePoint Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.31% -
What Is EyePoint Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
EyePoint Pharmaceuticals Stock Price Performance
-
Did EyePoint Pharmaceuticals Stock Go Up Last Month?
EyePoint Pharmaceuticals share price went down by -21.96% last month -
Did EYPT's Share Price Rise Over The Last Year?
EYPT share price rose by 36.44% over the past 1 year
What Is EyePoint Pharmaceuticals 52-Week High & Low?
-
What Is EyePoint Pharmaceuticals’s 52-Week High Share Price?
EyePoint Pharmaceuticals has traded as high as $30.99 over the past 52 weeks -
What Is EyePoint Pharmaceuticals’s 52-Week Low Share Price?
EyePoint Pharmaceuticals has traded as low as $5.86 over the past 52 weeks
EyePoint Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy EyePoint Pharmaceuticals?
-
How Much Debt Does EyePoint Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does EyePoint Pharmaceuticals Have?
Cash and short term investments quarterly total is $253.8M -
What Is EyePoint Pharmaceuticals’s Book Value Per Share?
Book value per share is 4.09
Is EyePoint Pharmaceuticals Cash Flow Positive?
-
What Is EYPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$113.5M -
What Is EyePoint Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $230.8M -
What Is EyePoint Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$170.5M
EyePoint Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
EYPT return on invested capital is -50.67% -
What Is EyePoint Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -35.24% -
What Is EYPT Return On Equity?
ROE is a measure of profitability and is -50.67%
EyePoint Pharmaceuticals Earnings Date & Stock Price
-
What Is EyePoint Pharmaceuticals's Stock Price Today?
A single share of EYPT can be purchased today for 8.35 -
What Is EyePoint Pharmaceuticals’s Stock Symbol?
EyePoint Pharmaceuticals trades on the nasdaq under the ticker symbol: EYPT -
When Is EyePoint Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for EyePoint Pharmaceuticals is scheduled on March 7, 2025 -
When Is EYPT's next ex-dividend date?
EyePoint Pharmaceuticals's next ex-dividend date is May 27, 2020 -
How To Buy EyePoint Pharmaceuticals Stock?
You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
EyePoint Pharmaceuticals Competitors
-
Who Are EyePoint Pharmaceuticals's Competitors?
Below is a list of companies who compete with EyePoint Pharmaceuticals or are related in some way:
EyePoint Pharmaceuticals Dividend Yield
-
What Is EYPT Dividend Yield?
EyePoint Pharmaceuticals’s dividend yield currently is 0% -
What Is EyePoint Pharmaceuticals’s Payout Ratio?
EyePoint Pharmaceuticals’s payout ratio is 0% -
When Did EyePoint Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is EyePoint Pharmaceuticals’s Dividend Per Share?
EyePoint Pharmaceuticals pays a dividend of $0.00 per share
EyePoint Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -0.17% |
| Revenue: | -30.77% | 1.6% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 33.45 |
| Upside from Last Price: | 300.65% |